GSA Capital Partners LLP Has $1.22 Million Stake in Cardlytics, Inc. (NASDAQ:CDLX)

GSA Capital Partners LLP lifted its stake in shares of Cardlytics, Inc. (NASDAQ:CDLX) by 1,273.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 382,315 shares of the company’s stock after purchasing an additional 354,474 shares during the period. GSA Capital Partners LLP owned approximately 0.77% of Cardlytics worth $1,223,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Quadrature Capital Ltd acquired a new position in shares of Cardlytics during the first quarter worth approximately $1,906,000. Renaissance Technologies LLC lifted its position in shares of Cardlytics by 711.9% during the second quarter. Renaissance Technologies LLC now owns 351,035 shares of the company’s stock worth $2,882,000 after purchasing an additional 307,800 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of Cardlytics by 2.7% during the first quarter. Vanguard Group Inc. now owns 2,211,595 shares of the company’s stock worth $32,046,000 after purchasing an additional 57,805 shares in the last quarter. SG Americas Securities LLC acquired a new position in shares of Cardlytics during the third quarter worth approximately $45,000. Finally, Bank of New York Mellon Corp lifted its position in shares of Cardlytics by 15.4% during the second quarter. Bank of New York Mellon Corp now owns 135,924 shares of the company’s stock worth $1,116,000 after purchasing an additional 18,179 shares in the last quarter. 68.10% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on CDLX shares. Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a report on Thursday, November 7th. Northland Capmk lowered shares of Cardlytics from a “strong-buy” rating to a “hold” rating in a report on Friday, August 16th. Bank of America lowered shares of Cardlytics from a “neutral” rating to an “underperform” rating and cut their price objective for the company from $4.00 to $3.50 in a report on Thursday, August 15th. Lake Street Capital lowered shares of Cardlytics from a “buy” rating to a “hold” rating and cut their target price for the stock from $18.00 to $5.00 in a report on Thursday, August 8th. Finally, Evercore ISI began coverage on shares of Cardlytics in a report on Friday, October 11th. They issued an “in-line” rating and a $4.00 target price on the stock. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $6.92.

Insider Transactions at Cardlytics

In other news, CEO Amit Gupta sold 22,607 shares of the stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $3.85, for a total transaction of $87,036.95. Following the completion of the sale, the chief executive officer now owns 178,519 shares of the company’s stock, valued at $687,298.15. This represents a 11.24 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders sold 43,573 shares of company stock valued at $151,612 over the last quarter. Corporate insiders own 4.40% of the company’s stock.

Cardlytics Trading Down 6.9 %

CDLX opened at $3.60 on Friday. The firm’s fifty day moving average is $3.73 and its two-hundred day moving average is $6.48. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.18 and a current ratio of 1.18. Cardlytics, Inc. has a twelve month low of $2.89 and a twelve month high of $20.52. The firm has a market cap of $182.70 million, a PE ratio of -0.59 and a beta of 1.61.

Cardlytics (NASDAQ:CDLX) last issued its quarterly earnings data on Wednesday, November 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.18. Cardlytics had a negative net margin of 93.55% and a negative return on equity of 110.67%. The company had revenue of $67.06 million during the quarter, compared to the consensus estimate of $57.77 million. During the same quarter in the prior year, the firm earned ($0.26) earnings per share. The firm’s revenue was down 15.1% compared to the same quarter last year. Equities research analysts anticipate that Cardlytics, Inc. will post -1.72 EPS for the current year.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.